DB
RVMD icon

Danske Bank’s Revolution Medicines RVMD Stock Holding History

Danske Bank’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.37M Buy
44,900
+41,800
+1,348% +$4.22M 0.01% 536
2025
Q4 		$247K Buy
3,100
+1,000
+48% +$65.6K ﹤0.01% 657
2025
Q3 		$98.1K Hold
2,100
– – ﹤0.01% 867
2025
Q2 		$77.3K Buy
2,100
+1,900
+950% +$73K ﹤0.01% 916
2025
Q1 		$7.07K Hold
200
– – ﹤0.01% 1133
2024
Q4 		$8.75K Sell
200
-500
-71% -$25.2K ﹤0.01% 1125
2024
Q3 		$31.7K Buy
+700
New +$30.5K ﹤0.01% 1272

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Danske Bank's RVMD Position: Q1 2026 in Review

Danske Bank increased its Revolution Medicines (RVMD) stake by 1,348% in Q1 2026, buying an estimated $4.22M and bringing the position to 44,900 shares worth $4.37M. The position accounts for 0.01% of the portfolio, ranked #536.

Danske Bank first reported a position in RVMD in Q3 2024 and has held it in 7 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Danske Bank held 44,900 shares of Revolution Medicines worth $4.37M as of Q1 2026.
  • Danske Bank bought 41,800 Revolution Medicines shares in Q1 2026, an estimated $4.22M.
  • Revolution Medicines made up 0.01% of Danske Bank's portfolio in Q1 2026, its #536 holding.
  • Danske Bank first reported a position in Revolution Medicines in Q3 2024 and has held it in 7 quarters since.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.